“Patient involvement” is the buzz word of the decade in healthcare. In this interview, Tony Hoos, the Head of Medical for Europe at Amgen talks about the need to embrace a new societal contract, one in which informed patients can and should have a meaningful say in the drug development process.

“If I had a serious condition, I would want to have a say in my own future. I would want to really understand what my data is, what my options are and I would want to take an active part in shaping my future therapies and ultimately my fate” , he explains.

Listen to the full interview below as we explored the needs of the patients today and the challenges to meet them: